World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
86
Citations
23281
World Ranking
1282
National Ranking
47

Medicine

D-Index
87
Citations
23481
World Ranking
13781
National Ranking
455

Allan Saul publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Allan Saul sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 338 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Allan Saul D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Allan Saul sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 86 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Allan Saul is affiliated with the Burnet Institute in Australia and has contributed extensively to the field of Medicine with a focus on infectious diseases and epidemiology. Their body of work includes 29 publications within medicine, highlighting subfields such as Infectious Diseases, Endocrinology, Ecology, Epidemiology, and Modeling and Simulation.

The scientist's main research topics cover a diverse range of subjects within infectious diseases and microbial studies. Key areas of work include:

  • Viral gastroenteritis research and epidemiology
  • Bacteriophages and microbial interactions
  • Escherichia coli research studies
  • COVID-19 epidemiological studies
  • COVID-19 and healthcare impacts
  • Clostridium difficile and Clostridium perfringens research
  • Pneumonia and Respiratory Infections

Allan Saul has published in several venues with repeated contributions to journals such as SSRN Electronic Journal and bioRxiv (Cold Spring Harbor Laboratory), both with three publications each. Other frequent publication venues include International Journal of Molecular Sciences (2 publications), Vaccines, and PLoS ONE.

Frequent collaborators include Francesca Micoli, Omar Rossi, Francesca Necchi, Brendan S. Crabb, and Margaret Hellard, with whom Saul has coauthored multiple papers across various topics.

Some of the recent papers authored or coauthored by Allan Saul are:

  • GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines, 2020, Vaccines
  • The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan city, 2021, PLoS ONE
  • Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults, 2021, EClinicalMedicine
  • Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus, 2020, International Journal of Molecular Sciences
  • Impact of Victoria's Stage 3 lockdown on COVID-19 case numbers, 2020, The Medical Journal of Australia

Best Publications

  • A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

    Blaise Genton;Inoni Betuela;Ingrid Felger;Fadwa Al-Yaman

  • Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

    David J Pombo;David J Pombo;Gregor Lawrence;Chakrit Hirunpetcharat;Christine Rzepczyk

  • Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

    Yimin Wu;Ruth D. Ellis;Donna Shaffer;Erica Fontes

  • Progress and challenges for malaria vaccines.

    Thomas L. Richie;Allan Saul

  • Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site.

    Michael Korsinczky;Nanhua Chen;Barbara Kotecka;Allan Saul

  • Discrimination of all members of the Anopheles punctulatus complex by polymerase chain reaction--restriction fragment length polymorphism analysis

    Nigel W. Beebe;Allan Saul

  • Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

    Ulrike Wille-Reece;Barbara J. Flynn;Karin Loré;Richard A. Koup

  • stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens.

    Qin Cheng;Nicole Cloonan;Katja Fischer;Jenny Thompson

  • Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria

    Elissa M. Malkin;David J. Diemert;Julie H. McArthur;John R. Perreault

  • In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response

    Michael C. Kennedy;Jin Wang;Yanling Zhang;Aaron P. Miles

  • Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes.

    G. N. Jakeman;A. Saul;W. L. Hogarth;W. E. Collins

  • Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

    Elissa M. Malkin;Anna P. Durbin;David J. Diemert;Jetsumon Sattabongkot

  • Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines

    Kazutoyo Miura;Andrew C. Orcutt;Olga V. Muratova;Louis H. Miller

  • Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum.

    Jason A. Smythe;M.Gregory Peterson;Ross L. Coppel;Alan J. Saul

  • Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin.

    E. P. Rock;K. Marsh;A. J. Saul;T. E. Wellems

  • Zooprophylaxis or zoopotentiation: the outcome of introducing animals on vector transmission is highly dependent on the mosquito mortality while searching.

    Allan Saul

  • Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria

    Anthony W. Stowers;Michael C. Kennedy;Brian P. Keegan;Allan Saul

  • A Randomized Controlled Phase 2 Trial of the Blood Stage AMA1-C1/Alhydrogel Malaria Vaccine in Children in Mali

    Issaka Sagara;Alassane Dicko;Ruth D. Ellis;Michael P. Fay

  • A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014)

    Ifeanyi Valentine Uche;Calman A. MacLennan;Allan Saul

  • Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.

    Rebecca A. O'Donnell;Allan Saul;Alan F. Cowman;Brendan S. Crabb

  • A research agenda for malaria eradication: vaccines.

    S. Abdulla;P. Agre;P.L. Alonso;M. Arevalo-Herrera

Frequent Co-Authors

Louis H. Miller
Louis H. Miller National Institute of Allergy and Infectious Diseases
Carole A. Long
Carole A. Long National Institute of Allergy and Infectious Diseases
Calman A. MacLennan
Calman A. MacLennan Bill & Melinda Gates Foundation
Qin Cheng
Qin Cheng Department of Defence
Kazutoyo Miura
Kazutoyo Miura National Institute of Allergy and Infectious Diseases
David L. Narum
David L. Narum National Institutes of Health
Robin F. Anders
Robin F. Anders La Trobe University
Rino Rappuoli
Rino Rappuoli Imperial College London
Peter J. Myler
Peter J. Myler Seattle Children's Hospital
Russell J. Howard
Russell J. Howard Immutep (Germany)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge beyond immunology, pursuing a Nurse Practitioner degree can be a promising option. Many students look for easy nurse practitioner programs to get into as a way to balance quality education with accessibility in admissions.

Mental health is a growing field within healthcare, and specializing as a Psychiatric-Mental Health Nurse Practitioner (PMHNP) offers impactful career opportunities. When selecting a program, it’s essential to consider clinical experience, and some of the best online pmhnp programs stand out for their exceptional clinical placement rates.

Cost is a critical factor for many students pursuing advanced nursing degrees. Identifying cheapest pmhnp programs can make graduate education more attainable without compromising on the quality of training.

Understanding salary potential is just as important as finding the right program. For example, exploring data on how much does a dnp make helps future nurse practitioners plan their financial and career goals effectively across different states.

Best Scientists Citing Allan Saul

Trending Scientists

Recently Published Articles